Inactief instrument

Andere talen LOTUS PHARM OTC Bulletin Board

Aandelen

LTUS

US5457151042

slotkoers OTC Bulletin Board Andere beurzen
- ^USD	-

2023

Amarin, Lotus Pharmaceuticals sluiten overeenkomst voor exclusieve distributie van Vazkepa in 10 Aziatische landen

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Lotus Pharmaceuticals Secures Three HR Asia Awards for 2024	08/07
Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia	07/06
Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth	10/11
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	12-09-23
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	14-08-23
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA	01-08-23
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	31-07-23
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia	27-03-23
Lotus revenues grow by 16% and profit doubles year over year	13-03-23
Lotus acquires Alimta in Taiwan from Lilly	14-12-22
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders	12-07-22
Lotus Reports Solid Performance in First Quarter of 2022	16-05-22
Lotus Pharmaceuticals : Unaudited Financial Statement	30-03-22
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly	23-03-22
Lotus achieves another record high EPS for FY2021	17-03-22
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal	29-11-21
Thai oil firm PTT expands pharma business with $475 million Alvogen deal	26-11-21
Lotus Pharmaceuticals : Informational Disclosure	22-11-21
Lotus Pharmaceuticals : Unaudited Financial Statements	22-11-21
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	28-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen LOTUS PHARM OTC Bulletin Board

Aandelen

LTUS

US5457151042

Andere talen

Filters